Clinical Trial Update: Ipratropium Spray for Drooling Saliva in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ipratropium spray to reduce drooling in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ipratropium spray (ipratropium)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED